<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H5022D7792A2B4C3B99CACB9875640FED" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 2273 IH: Charlotte’s Web Medical Access Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-05-01</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2273</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170501">May 1, 2017</action-date><action-desc><sponsor name-id="P000605">Mr. Perry</sponsor> (for himself, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="C000059">Mr. Calvert</cosponsor>, <cosponsor name-id="C000754">Mr. Cooper</cosponsor>, <cosponsor name-id="C001068">Mr. Cohen</cosponsor>, <cosponsor name-id="H001048">Mr. Hunter</cosponsor>, <cosponsor name-id="S000244">Mr. Sensenbrenner</cosponsor>, <cosponsor name-id="P000593">Mr. Perlmutter</cosponsor>, <cosponsor name-id="S001192">Mr. Stewart</cosponsor>, <cosponsor name-id="L000579">Mr. Lowenthal</cosponsor>, <cosponsor name-id="W000812">Mrs. Wagner</cosponsor>, <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>, <cosponsor name-id="W000804">Mr. Wittman</cosponsor>, <cosponsor name-id="S001157">Mr. David Scott of Georgia</cosponsor>, <cosponsor name-id="O000170">Mr. O'Rourke</cosponsor>, and <cosponsor name-id="J000255">Mr. Jones</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committees on <committee-name committee-id="HJU00">the Judiciary</committee-name>, and <committee-name committee-id="HBA00">Financial Services</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to exclude cannabidiol and cannabidiol-rich plants from the definition of marihuana, and for other purposes.</official-title></form><legis-body id="H94C3D80CDC4A402DA65703947DBEA77E" style="OLC"> 
<section id="H2143182925AB4AC9B58D731285AC2A7A" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Charlotte’s Web Medical Access Act of 2017</short-title></quote>.</text></section> <section id="H24551D1CE4394139BA56DF67BD0B70CA"><enum>2.</enum><header>Exclusion of cannabidiol and cannabidiol-rich plants from definition of marihuana</header> <subsection id="H72E0F274F6CB478B9CA9279AC68F6509"><enum>(a)</enum><header>In general</header><text>Section 102 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802</external-xref>) is amended in paragraph (16)—</text> 
<paragraph id="H5F371194DCF941439935EF5193814C42"><enum>(1)</enum><text>by striking <quote>(16) The</quote> and inserting <quote>(16)(A) The</quote>; and</text></paragraph> <paragraph id="HE59E5E4C209548A2AC4301C4008B751F"><enum>(2)</enum><text>by adding at the end the following:</text> 
<quoted-block id="HEDAB91A8A87545B7B8F51D71293D8AE9" style="OLC"> 
<subparagraph id="H8F9184286D6F4F69BDFE758E4FAFE501" indent="up1"><enum>(B)</enum><text>Cannabidiol and cannabidiol-rich plants—</text> <clause id="HE967EF4AD2BA40ADB4078C8C43EAF5F3"><enum>(i)</enum><text>are excluded from the definition of marihuana under subparagraph (A); and</text></clause> 
<clause id="HB0FA21B33B674CC88BAAD316961B91F0"><enum>(ii)</enum><text>shall not be treated as controlled substances under this Act.</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection> <subsection id="H09A90FEEFF80457AB15382FBF6E54665"><enum>(b)</enum><header>Definitions</header><text>Section 102 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802</external-xref>), as amended, is further amended by adding at the end the following:</text> 
<quoted-block id="H4030AE72E98A431586F0FEFD30D2F4B8" style="OLC"> 
<paragraph id="HF8EB6CD517DA4330A869D116B1A9C077"><enum>(57)</enum><text>The term <term>cannabidiol-rich plant</term> means the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.</text></paragraph> <paragraph id="HA7EECF2ADB244818890FFB4C844743E1"><enum>(58)</enum><text>The term <term>cannabidiol</term> means the substance cannabidiol, as derived from a cannabidiol-rich plant.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> 
<section id="HFC8886D455D7421BA6B0A1727F7CF182"><enum>3.</enum><header>Other limitations</header> 
<subsection id="H48E0EF45033B42A0BF2C0A6DA042F5CA"><enum>(a)</enum><header>Non-Applicability of Federal Food, Drug, and Cosmetic Act</header><text>The Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301</external-xref> et seq.) shall not apply to cannabidiol or cannabidiol-rich plants as those terms are defined in section 102 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802</external-xref>) as amended by this Act.</text></subsection> <subsection id="H184B3A4E32EB4CA59C23AEB0FBBC884E"><enum>(b)</enum><header>State law</header><text>Nothing in this Act shall prohibit or otherwise restrict any activities related to the use, production, or distribution of marijuana in a State in which such activities are legal under State law.</text></subsection></section> 
<section id="HD74D7DCFA5D74B47A14A5FF08B84024B"><enum>4.</enum><header>Sense of Congress with respect to suspicious activity reports</header><text display-inline="no-display-inline">It is the sense of the Congress that, after the date of the enactment of this Act, a transaction should not be treated as a suspicious transaction for purposes of section 5318(g) of title 31, United States Code, solely because such transaction involved cannabidiol or a cannabidiol-rich plant.</text></section> <section id="H538C86F92FF9468F9501BB6320352247"><enum>5.</enum><header>Sunset provision</header><text display-inline="no-display-inline">The provisions of this Act, and the provisions inserted into the Controlled Substances Act by this Act, shall cease to apply on the date that is 3 years after the date of enactment of this Act.</text></section> 
</legis-body></bill>

